Eli Lilly & Co. has already produced billions of doses of its next-generation weight-loss pill, anticipating massive global demand ahead of a potential launch next year.
“We’ve already made, actually, billions of doses preparing for the launch,” Chief Executive Officer Dave Ricks said Monday at an event hosted by the Economic Club of Chicago. “That will make this sort of the ‘GLP-1 for all,’ and I think really makes a difference in human health at a global level.”